License – Socially Bharat

socially bharat
October 30, 2024
5 Mins Read

US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)

Shanghai, China & JERSEY CITY, N.J., United States: Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the

62 Views
0 Comments

socially bharat
September 12, 2024
5 Mins Read

ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors

Garching, Munich, Germany & Lausanne, Switzerland: ITM gains exclusive global development and commercialization rights to Debiopharm’s first-in-class, peptide-based theranostic

68 Views
0 Comments

Socially Bharat is your comprehensive source for Social news, NGO’s, and expert insights from across India.

Quick Links

Contact Us

Stay Updated

Share Your Message!